REZCANTA Canadian Trademark Information
Pharmaceutical preparations for treating central nervous system diseases or disorders; pharmaceutical preparations for treating attention-deficit/hyperactivity disorder (ADHD); pharmaceutical preparations for treating eating disordersPharmaceutical preparations for treating central nervous system diseases or disorders, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular mobility disorders, spinal cord diseases, encephalitis, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease, Parkinson's Disease OFF (hypomobility) episodes, sleep disorders, smoking habits and addictions, obesity, eating disorders, binge eating disorders, cognitive disorders, depression, ADHD, schizophrenia, anxiety, pain, migraine and substance abuse and respiratory system diseases and disorders, PTSD, bipolar disorder, bipolar depression, psychiatric disorders; pharmaceutical preparations for treating attention-deficit hyperactivity disorder (ADHD); pharmaceutical preparations for treating eating disordersPharmaceutical preparations for treating central nervous system diseases or disorders; pharmaceutical preparations for treating attention-defic...
Perfect for these industries
Words that describe this mark
pharmaceutical preparations treating central nervous diseases disorders pharmaceutical preparations treating attentiondeficithyperactivity disorder adhd pharmaceutical preparations treating eating disorderspharmaceutical preparations treating central nervous diseases disorders central nervous infections brain diseases central nervous movement disorders
On Wednesday, August 28, 2019, a canadian trademark registration was filed for
REZCANTA by Sunovion Pharmaceuticals Inc. *********, **********, ***** ****.
The Canadian IP office has given the trademark application number of
1982526.
The current status of this trademark filing is Registration published.
The REZCANTA
trademark is filed in the description of
Pharmaceutical preparations for treating central nervous system diseases or disorders; pharmaceutical preparations for treating attention-deficit/hyperactivity disorder (ADHD); pharmaceutical preparations for treating eating disorders
,
Pharmaceutical preparations for treating central nervous system diseases or disorders, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular mobility disorders, spinal cord diseases, encephalitis, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease, Parkinson's Disease OFF (hypomobility) episodes, sleep disorders, smoking habits and addictions, obesity, eating disorders, binge eating disorders, cognitive disorders, depression, ADHD, schizophrenia, anxiety, pain, migraine and substance abuse and respiratory system diseases and disorders, PTSD, bipolar disorder, bipolar depression, psychiatric disorders; pharmaceutical preparations for treating attention-deficit hyperactivity disorder (ADHD); pharmaceutical preparations for treating eating disorders
,
Pharmaceutical preparations for treating central nervous system diseases or disorders; pharmaceutical preparations for treating attention-deficit/hyperactivity disorder (ADHD); pharmaceutical preparations for treating eating disorders
.
100% Satisfaction Guarantee
protect your valuable brand now.
Classification Information